As noted in this New York Times article, so-called specialty drugs for diseases like rheumatoid arthritis have a narrow use and high costs, leaving the most vulnerable patients with huge bills. Read more…
MCN | Medical Consultants Network
The Power of a Second Look
Leave a Reply